PTH and secondary hyperparathyroidism: The underlying pathophysiological mechanisms include stimulation of Fibroblast Growth Factor (FGF23) and PTH, suppression of 1α-hydroxylase, and direct cellular effects resulting in secondary hyperparathyroidism, impaired mineralization, enhanced bone resorption, and disturbed skeletal homeostasis.